Investigated the safety of intra-renal arterial transfusion of autologous CD34+ cells and time courses of creatinine levels, endothelial dysfunction biomarkers and micro-RNAs in chronic kidney disease patients-phase I clinical trial

This was a phase I clinical trial to investigate the safety of autologous peripheral-blood-derived CD34+ cell therapy for patients with chronic kidney disease (CKD-treatment) (i.e., at Stages III and IV). Between November 2014 and October 2015, a total of 10 study patients were prospectively enrolle...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Mel S., Lee, Fan-Yen, Chen, Yung-Lung, Sung, Pei-Hsun, Chiang, Hsin-Ju, Chen, Kuan-Hung, Huang, Tien-Hung, Chen, Yi-Ling, Chiang, John Y., Yin, Tsung-Cheng, Chang, Hsueh-Wen, Yip, Hon-Kan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5392283/
https://www.ncbi.nlm.nih.gov/pubmed/28148896
http://dx.doi.org/10.18632/oncotarget.14831

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5392283/
https://www.ncbi.nlm.nih.gov/pubmed/28148896
http://dx.doi.org/10.18632/oncotarget.14831

Ejemplares similares